QTTB

Q32 Bio Inc.

QTTB · CIK 1661998 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$0M
20182024
Net Income−$48M
20182024
Operating CF−$68M
20182024
Free Cash Flow−$68M
20182024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
SG&A Expense———————
Operating Income$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
Net Income$-0.0B$-0.1B$-0.0B$-0.1B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-5.12$-1.95$-0.09————
EPS (Diluted)$-6.58$-1.95$-0.09————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.1B$0.1B$0.2B$0.2B$0.3B$0.3B$0.3B
Current Assets$0.1B$0.1B$0.2B$0.2B$0.2B$0.3B$0.2B
Cash & Equivalents$0.1B$0.0B$0.0B$0.1B$0.2B$0.1B$0.0B
Total Liabilities$0.1B$0.0B$0.1B$0.0B$0.1B$0.1B$0.1B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.1B$0.2B$0.2B$0.2B$0.3B$0.2B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$0.0B$0.1B$0.0B$-0.1B$0.2B$-0.1B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.1B$0.0B$0.0B$0.1B$0.1B$0.2B$0.2B
← Companies